Hipra Scientific, S.l.u
Clinical trials sponsored by Hipra Scientific, S.l.u, explained in plain language.
-
New booster shot tested for vulnerable adults
⭐️ VACCINE ⭐️ CompletedThis study tested a new COVID-19 booster shot in adults with conditions that weaken their immune systems, like HIV or kidney disease. The goal was to see if the extra dose was safe and helped their bodies build a stronger defense against the virus. Researchers measured antibody l…
Phase: PHASE2, PHASE3 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:12 UTC
-
New booster shot tested against current vaccine
⭐️ VACCINE ⭐️ CompletedThis study tested a new COVID-19 booster vaccine to see if it was as safe and effective as an already approved booster shot. It involved 913 adults who had already received their primary COVID-19 vaccinations and at least one booster. Researchers compared the new vaccine's safety…
Phase: PHASE2, PHASE3 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:34 UTC
-
New booster shot tested as potential COVID-19 defense
⭐️ VACCINE ⭐️ CompletedThis study tested a new COVID-19 booster vaccine called PHH-1V. Researchers compared it to the Pfizer booster shot in adults who were already fully vaccinated. The goal was to see if the new vaccine was as safe and effective at triggering an immune response, including against new…
Phase: PHASE2 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:18 UTC
-
New COVID booster tested on teens shows promise
⭐️ VACCINE ⭐️ CompletedThis study tested a COVID-19 booster vaccine called BIMERVAX in teenagers aged 12 to 18. Researchers wanted to see if it was safe and how well it boosted the immune system in teens who had already received two Pfizer shots. They followed 242 participants for a year, checking for …
Phase: PHASE2 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 02, 2026 15:25 UTC